NEXVOUND
Live / Applied — Non-final action mailed (as of 06 Jan 2026)
What this means for you
Not registered yet, but its 21 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99509700
- Mark type
- Design + words
- Filed
- 21 Nov 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.
Owner
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 06 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION WRITTEN
- 22 Dec 2025 — ASSIGNED TO EXAMINER
- 17 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 17 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2025 — NEW APPLICATION ENTERED